Best Central Lab Vendors for Clinical Trials (2026)

Who this guide is for

This guide is for clinical operations leads, clinical scientists and biotech teams choosing a central laboratory for a multi-site trial, or reviewing whether the lab bundled into a CRO proposal is the right one. It is also for teams adding a specialty partner, for example for biomarker, genomic or bioanalytical work, alongside an existing safety lab.

If you are looking for the best central lab vendors for clinical trials, treat the vendor cards and table on this page as a starting point, not a verdict. They show which central laboratory vendors are listed and how each profile describes its focus; they cannot tell you whether a lab runs your assay, covers your countries or meets your turnaround needs. Use the criteria below to decide what to ask before you commit.

What a central lab vendor does — and when you need one

A central laboratory tests samples from every site in a trial with the same methods, instruments and reference ranges, so results can be compared and pooled. The service is much wider than testing. A central lab typically designs and supplies visit-specific sample collection kits, manages shipping logistics from sites, receives and accessions samples, runs safety and specialty assays, stores samples for later testing, reports results to sites and sponsors, and transfers data into the trial database.

Labs in this category range from global safety-lab networks to specialty labs focused on biomarkers, genomics, immunology or bioanalysis of drug concentrations. Many sponsors use a primary central lab for routine safety testing and one or more specialty labs for exploratory or endpoint assays, coordinated through the primary lab or directly by the sponsor.

Typical trigger points are a multi-site or multinational study where comparable lab data matter, an endpoint that depends on a laboratory measure, a biomarker used to select or stratify patients, pharmacokinetic sampling, or a need to store samples for future research.

How to evaluate a central lab vendor

Assay menu and validation

Start with the protocol's schedule of assessments and ask the lab to map every test to its menu. For standard safety panels this is usually straightforward. For specialty and biomarker assays, ask whether the method is already validated, who validated it, what its performance characteristics are, and what work is needed if it must be transferred or developed. A test that needs development can add months.

Geographic coverage and logistics

Ask which of your countries the lab serves from which facilities, how samples reach them, and what the realistic transit times are from your most remote sites. Ask about customs, import and export permits for biological samples, and how weekend and holiday collections are handled. Logistics failures, not testing errors, cause most lost samples.

Kits, sample stability and pre-analytical quality

Many lab problems start before the sample reaches the lab. Ask how kits are designed and labelled, how sites are trained, what stability data support each sample type and storage condition, and how the lab measures and reports pre-analytical issues such as haemolysed, mislabelled or late samples.

Accreditation and quality systems

Ask which accreditations each testing facility holds, such as CLIA certification and CAP accreditation for United States testing or ISO 15189 for medical laboratory quality, and when they were last inspected. Ask how the lab applies good clinical practice and good clinical laboratory practice principles, and request its most recent sponsor audit outcomes at the level it can share.

Reference ranges, alerts and reporting

Ask how reference ranges are set and documented, how alert and panic values are communicated to investigators, how quickly results reach sites, and how the lab handles results that could unblind a study. For safety data, the alert process matters as much as the test itself.

Data transfer and integration

Lab data must reach the clinical database cleanly. Ask for sample data transfer specifications, how often transfers run, how the lab reconciles sample records against visits in the database, and how it handles corrections. Ask whether it can deliver data in a CDISC-aligned format to make SDTM conversion easier.

Biorepository and consent management

If samples will be stored, ask about storage conditions, monitoring and backup, how consent restrictions are tracked against each sample, and how retention and destruction are documented. Storage rules must match the informed consent form and local law.

Turnaround and service levels

Ask for the lab's standard turnaround from sample receipt to reported result for each test type, how it measures and reports that turnaround, and what happens when it is missed. Where eligibility depends on a central result, turnaround decides how long patients wait in screening. Agree service levels in the contract and review them in governance meetings.

Specialty and biomarker capability

For biomarker-led studies, ask about the technology platforms the lab runs, experience with fit-for-purpose validation of exploratory assays, and whether a patient-selection assay could fall under in vitro diagnostic regulation, such as performance study rules under Regulation (EU) 2017/746.

Central lab vendors at a glance

The table below lists central laboratory vendors whose profiles describe sample handling, specimen, assay or biomarker work, so you can compare service model, footprint and study coverage before opening individual pages. Imaging core labs, which also appear in the central lab category, are covered in the guide to imaging CROs.

The fields come from each vendor's Clinical Vendor Compare profile. Several records use similar standard wording for their best fit and strengths, so the table separates labs mainly by service model, headquarters and therapeutic focus. A field reading Mixed or Generalist means the record does not narrow the phases or areas covered; it is not evidence of breadth. Confirm assay availability, country coverage and accreditation directly.

Vendor profiles

Q2 Solutions

Q2 Solutions is listed as a global central lab headquartered in the United States, with a focus on laboratory and biomarker services and a therapeutic remit that includes biomarker and companion diagnostic work. Its profile positions it for programmes that want central lab services aligned with a broader data and trial ecosystem. Where to probe: its record notes that highly novel assays may need specialist add-ons, so map any non-standard tests to its menu early.

Cerba Research

Cerba Research's record describes a global central lab headquartered in France, covering Phase I to Phase III studies with a generalist remit and a focus on central labs and diagnostics. Its stated best fit is studies needing standardised sample handling and central reporting. Where to probe: ask which facility would test samples from each of your regions and how transit times compare across them.

Almac Diagnostic Services

Almac Diagnostic Services is listed with a biomarker and diagnostic services model, headquartered in the United Kingdom with a global footprint, covering Phase I to Phase IV with a focus on biomarker-driven specialty central lab work. Where to probe: for a biomarker used to select patients, ask what support the team offers for assay validation and any in vitro diagnostic regulatory pathway, and how it coordinates with a safety-lab partner.

MLM Medical Labs

MLM Medical Labs' record lists a functional and specialist central lab headquartered in Germany, covering Phase I to Phase IV, with central lab, assay and specialty diagnostic services. Where to probe: ask which assays it runs in-house versus through partners, and how its logistics cover sites outside Europe if your study is multinational.

Synexa Life Sciences

Synexa Life Sciences is listed as a specialty lab headquartered in South Africa with a footprint its record describes as covering the United Kingdom, Finland, South Africa and global work, focused on biomarker and bioanalytical lab services across Phase I to Phase IV. Where to probe: ask which facility would run your assays, and how samples from your sites would be routed and stored.

LabConnect

LabConnect's record describes end-to-end analytical and logistical services from a United States headquarters, aimed at biomarker-rich, specialty or analytically complex studies, including cell and gene therapy work. Its profile emphasises sample tracking and logistical coordination. The record notes that deeper evidence enrichment is still pending. Where to probe: ask which testing it performs itself and which it coordinates through partner labs, and how it tracks chain of custody across them.

ACM Global Laboratories

ACM Global Laboratories is listed as a global central lab headquartered in the United States, covering preclinical work through Phase III, with a generalist remit that includes infectious disease. Its stated best fit is studies needing standardised sample handling and central reporting. Where to probe: ask about its coverage for your countries and its kit and resupply process for sites with irregular visit patterns.

QPS Bioanalysis

QPS Bioanalysis' record lists a functional and specialist lab headquartered in the United States, focused on bioanalysis from discovery through clinical development, with translational work in its remit. That makes it relevant to drug-concentration and pharmacokinetic testing rather than routine safety labs. Where to probe: ask for its method validation approach and how it would coordinate sample flow with your safety-lab provider.

Eurofins Central Laboratory

Eurofins Central Laboratory's record describes a global central lab and bioanalytical platform headquartered in Luxembourg, positioned for sponsors who need assay breadth and high-capacity global lab support. The record notes that deeper evidence enrichment is still pending. Where to probe: ask how a large network keeps methods and reference ranges consistent across facilities, and who your single point of contact would be.

Adaptive Biotechnologies Biomarker Services

This record lists sponsor-facing central lab capability with a global footprint and a generalist remit across Phase I to Phase IV. The profile describes its services in general terms. Where to probe: ask which specific biomarker assays it offers, whether they are validated for your intended use, and how it works alongside a primary central lab for safety testing.

Engagement and pricing models

Central lab costs are usually built from several components: project setup and management, kit design and production, per-test or per-visit testing fees, logistics and courier charges, storage fees for samples kept over time, and data management and transfer. Specialty assays may carry separate development or validation fees.

The main cost drivers are the number of visits and tests per visit, the number of countries and sites, the share of samples needing frozen or time-critical shipment, assay development, and the length of storage. Logistics often costs more than sponsors expect, so ask for a realistic estimate based on your site list. Agree how unused kits, failed shipments and protocol amendments that add tests will be charged.

Questions to put in your RFP

• Can you map every test in our schedule of assessments to a validated method on your menu?
• Which facility will test samples from each of our countries, and what are the realistic transit times?
• Which accreditations does each testing facility hold, and when were they last inspected?
• How are kits designed, labelled, resupplied and tracked against expiry?
• What stability data support each sample type and storage condition?
• How do you report pre-analytical issues, such as unusable or mislabelled samples, and how quickly?
• How are alert values communicated to investigators, and how do you prevent unblinding through results?
• Can you share a sample data transfer specification and your reconciliation process?
• How do you track consent restrictions for stored samples and document destruction?
• Which tests do you perform in-house, and which are sent to partner labs?
• What is excluded from the quote, and how are failed shipments and unused kits charged?

Due-diligence red flags

• Assays described as available that turn out to need development or transfer.
• No clear answer on which facility tests samples from your regions.
• Accreditation claims that cannot be matched to a specific facility.
• No stability data for the sample types and timings in your protocol.
• Kit and logistics costs left vague, or quoted only per test.
• No routine reporting of sample quality issues back to sites.
• Partner labs used for key tests without disclosure or oversight arrangements.
• Storage terms that do not match your informed consent form.

Shortlist on Clinical Vendor Compare

Start in the vendor directory and filter for central lab to see every listed laboratory. Open profiles to check stated focus, then place a few side by side on the compare page to separate global safety-lab networks from specialty and bioanalytical labs. Lab data flow into the clinical database, so read the guide to data management vendors as well. When your scope is clear, use the sponsor RFP tool to brief laboratories on your schedule of assessments, countries and sample volumes. If you have worked with any of these labs, please write a review: published reviews are what give the next buyer an evidence base.